Peña-Tauber, Andrés, Hernandez Arriaza, Ricardo, Reil, Dylan, Muntaner, Manon, Park, Junyoung and Sims, Rebecca  ORCID: https://orcid.org/0000-0002-3885-1199
2026.
Genetic modifiers of ABCA1 activity interact with APOE isoforms to mediate Alzheimer’s disease risk.
Annals of Neurology
100
(4)
, pp. 737-750.
10.1002/ana.78303
|
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (826kB) | Preview |
Abstract
Objective: ATP-binding cassette transporter A1 (ABCA1) has been associated with Alzheimer's disease (AD), but the mechanisms by which it impacts disease risk are unknown. ABCA1 is known to bind apolipoprotein E (ApoE) and catalyze apolipoprotein lipidation. We explored whether genetic variants altering ABCA1 function interact with APOE isoforms to modify AD risk. Methods: Using data from the Alzheimer's Disease Sequencing Project (ADSP), UK Biobank, and the Alzheimer Disease European Sequencing consortium, we assessed the impact of ABCA1 variants on AD risk in APOE subgroups and tested for statistical interactions with APOE ε2 and ε4 in an all-APOE cohort. We first examined damaging nonsynonymous ABCA1 variants previously associated with AD. We then constructed a measure of predicted ABCA1 activity based on HDL-associated variants and tested its association with AD risk. Finally, we explored potential pathogenic mechanisms of missense variants of interest. Results: Damaging nonsynonymous ABCA1 variants had differential AD risk effects between APOE genotype groups and exhibited interaction effects with APOE ε2 and ε4. Predicted ABCA1 activity based on HDL-associated variants was associated with reduced AD risk and interacted with APOE ε4. Replication analyses suggested similar differences in effect size of ABCA1 variants between APOE groups and had concordant effect directions, although not statistically significant, in the APOE interaction model. ABCA1 missense variants N1800H and E1172D were strongly associated with plasma HDL and interacted with APOE in AD risk. In cell-based assays, ABCA1-N1800H showed plasma membrane localization defects potentially driven by misfolding. Interpretation: Genetic modifiers of ABCA1 activity interact with APOE isoforms to alter AD risk. ANN NEUROL 2026
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Additional Information: | For full author list see https://doi.org/10.1002/ana.78303 |
| Publisher: | Wiley-Blackwell |
| ISSN: | 0364-5134 |
| Date of First Compliant Deposit: | 10 August 2026 |
| Date of Acceptance: | 18 June 2026 |
| Last Modified: | 12 Oct 2026 13:30 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/188800 |
Actions (repository staff only)
 |
Edit Item |
Altmetric
Altmetric